Senior insider sale
Ex VP, Intern'l Operations at AURINIA PHARMACEUTICALS INC. — senior position signals high conviction
$11.37M
717.69K shares
What this filing means
DONLEY MATTHEW MAXWELL plans to sell 717.69K shares of AURINIA PHARMACEUTICALS INC. valued at approximately $11.37M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/11/2026ACC: 0001950047-26-004310
Officer· Ex VP, Intern'l Operations
Since Jan 2021
717.69K
Shares to sell
$11.37M
Approx. market value
717.69K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Exercise of options under a registered plan
Cash
5/11/2026
717.69KTotal acquired717.69K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/11/2026 | Exercise of options under a registered plan Cash | 717.69K | — |
| Total | 717.69K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
717.69K
Market value
$11.37M
5/11/2026
Total
Units
717.69K
Value
$11.37M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
5/11/2026 | 717.69K | $11.37M | NASDAQ | Planned |
| Total | 717.69K | $11.37M | ||